| For: | Deng LY, Wang JP, Gui ZF, Shen LZ. Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancer. World J Gastroenterol 2011; 17(24): 2958-2964 [PMID: 21734808 DOI: 10.3748/wjg.v17.i24.2958] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i24/2958.htm |
| Number | Citing Articles |
| 1 |
Viktorija Preitakaitė, Arūnas Kazlauskas, Agota Aučynaitė, Kamilė Butkutė, Ringailė Lapinskaitė, Nina Urbelienė, Audrius Laurynėnas, Rolandas Meškys. Bacterial cytidine deaminases as versatile activators of fluoropyrimidine nucleoside prodrugs. European Journal of Medicinal Chemistry 2025; 296 doi: 10.1016/j.ejmech.2025.117860
|
| 2 |
Parisa Vosough, Asma Vafadar, Samaneh Naderi, Shayan Khalili Alashti, Sara Karimi, Cambyz Irajie, Amir Savardashtaki, Saeed Taghizadeh. Escherichia coli cytosine deaminase: Structural and biotechnological aspects. Biotechnology and Applied Biochemistry 2024; 71(1) doi: 10.1002/bab.2516
|
| 3 |
Sebastian Lange, Johanna Lampe, Sascha Bossow, Martina Zimmermann, Wolfgang Neubert, Michael Bitzer, Ulrich M. Lauer. A Novel Armed Oncolytic Measles Vaccine Virus for the Treatment of Cholangiocarcinoma. Human Gene Therapy 2013; 24(5) doi: 10.1089/hum.2012.136
|
| 4 |
Sven Hagen, Tobias Baumann, Hanna J. Wagner, Volker Morath, Beate Kaufmann, Adrian Fischer, Stefan Bergmann, Patrick Schindler, Katja M. Arndt, Kristian M. Müller. Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy. Scientific Reports 2014; 4(1) doi: 10.1038/srep03759
|
| 5 |
Ana Rama, Rosa Hernandez, Gloria Perazzoli, Miguel Burgos, Consolación Melguizo, Celia Vélez, Jose Prados. Specific Colon Cancer Cell Cytotoxicity Induced by Bacteriophage E Gene Expression under Transcriptional Control of Carcinoembryonic Antigen Promoter. International Journal of Molecular Sciences 2015; 16(6) doi: 10.3390/ijms160612601
|
| 6 |
Nejat Düzgüneş. Suicide Gene Therapy. Methods in Molecular Biology 2019; 1895 doi: 10.1007/978-1-4939-8922-5_1
|
| 7 |
Zahra Karjoo, Xuguang Chen, Arash Hatefi. Progress and problems with the use of suicide genes for targeted cancer therapy. Advanced Drug Delivery Reviews 2016; 99 doi: 10.1016/j.addr.2015.05.009
|
| 8 |
Obeid M. Malekshah, Xuguang Chen, Alireza Nomani, Siddik Sarkar, Arash Hatefi. Enzyme/Prodrug Systems for Cancer Gene Therapy. Current Pharmacology Reports 2016; 2(6) doi: 10.1007/s40495-016-0073-y
|
| 9 |
Yu Zhong Peng, Li Jun Yang, Hang Hong Lo, Betty Yuen Kwan Law, Vincent Kam Wai Wong. New Nanomaterials and Techniques for Tumor-targeted Systems. 2020; doi: 10.1007/978-981-15-5159-8_6
|
| 10 |
Louay Abo Qoura, Elena Morozova, С. S. Ramaa, Vadim S. Pokrovsky. Smart nanocarriers for enzyme-activated prodrug therapy. Journal of Drug Targeting 2024; 32(9) doi: 10.1080/1061186X.2024.2383688
|